Drug Type Small molecule drug |
Synonyms methylphanidate + cyproheptadine |
Action antagonists, agonists |
Mechanism 5-HT receptor antagonists(Serotonin (5-HT) receptor antagonists), ADRA2 agonists(Adrenergic receptors alpha-2 agonists), Histamine receptor antagonists |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Attention Deficit Disorder With Hyperactivity | Preclinical | United States | - |